[The principles of cancer treatment--changes in chemotherapy].
Sugimura
Takashi
T
D036002:ADP Ribose Transferases; D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001549:Benzamides; D002945:Cisplatin / Q000494:pharmacology; D004338:Drug Combinations; D005472:Fluorouracil / Q000494:pharmacology; D011905:Genes, ras / Q000235:genetics; D006801:Humans; D000068877:Imatinib Mesylate; D019476:Insect Proteins / Q000737:chemistry / Q000494:pharmacology; D008175:Lung Neoplasms / Q000188:drug therapy; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy*; D009386:Neoplastic Syndromes, Hereditary / Q000235:genetics; D010094:Oxonic Acid / Q000494:pharmacology; D010879:Piperazines / Q000737:chemistry / Q000494:pharmacology; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D011725:Pyridines / Q000494:pharmacology; D011743:Pyrimidines / Q000737:chemistry / Q000494:pharmacology; D015398:Signal Transduction; D005641:Tegafur / Q000494:pharmacology; D014407:Tumor Cells, Cultured / Q000187:drug effects
D000970:Antineoplastic Agents; D001549:Benzamides; D004338:Drug Combinations; D019476:Insect Proteins; D010879:Piperazines; D011725:Pyridines; D011743:Pyrimidines; C113557:pierisin protein, insect; C079198:S 1 (combination); D005641:Tegafur; D010094:Oxonic Acid; D000068877:Imatinib Mesylate; D036002:ADP Ribose Transferases; D011505:Protein-Tyrosine Kinases; D002945:Cisplatin; D005472:Fluorouracil